鶹Ů

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • 鶹Ů Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Community Health Workers
  • Rural Health Payout
  • Florida’s KidCare
  • LGBTQ+ Youth Crisis Line
  • Device Coverage by Medicare

TRENDING TOPICS:

  • Community Health Workers
  • Rural Health Payout
  • Florida’s KidCare
  • LGBTQ+ Youth Crisis Line
  • Device Coverage by Medicare

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Apr 4 2024

Full Issue

Biden, Sanders Share A Podium To Promote Low Drug Prices Effort

President Joe Biden was joined by Sen. Bernie Sanders (I) at the White House Wednesday to speak about the problem of high prescription drug costs, with an emphasis on asthma inhalers — including mention of how pharmacy benefit managers can stymie efforts to get lower-price drugs to patients.

Sen. Bernie Sanders (I) joined President Biden at the White House podium Wednesday, with the president hoping that the fiery Vermont senator can help tap into popular frustrations against pharmaceutical companies and boost a drug-price campaign ignored by many Americans. Biden and Sanders discussed their joint efforts to lower the out-of-pocket cost of inhalers for tens of millions of Americans who rely on the devices to treat asthma and other conditions. (Diamond, 4/3)

“Bernie, you and I have been fighting this for 25 years,” Biden said to Sanders ... “Finally, finally we beat Big Pharma. Finally.” Both men touted the lower health care costs that come through the Democrats’ sweeping climate, health care and tax package that Biden signed into law in 2022. It caps various health care costs for those on Medicare, including $35 a month for insulin and $2,000 a year for prescription drugs. No Republican lawmakers voted for the law. (Superville, 4/3)

Alex Schriver, a spokesperson for trade group PhRMA, defended industry practices, calling the White House event "another missed opportunity to address the real barriers between patients and their medicines." "When companies have introduced lower-priced versions of their medicines, insurers and PBMs (pharmacy benefit managers) have refused to cover them because they make less money," Schriver said. (Holland and Bose, 4/3)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
  • Tuesday, April 21
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 鶹Ů